The result showed that patients with active SLE had higher level of circulating IL-17 than inactive SLE patients (pooled SMD = 0.95, 95% CI: 0.38-1.53; I2 = 90.5%, P < 0.001) (Figure 3). This evidence concerns the gene IL17A and systemic lupus erythematosus.